Business

New start-up companies are constantly commercialising new technologies and services. Genomics is ripe for investment right now.

New episode of Signal podcast calls shenanigans on the tactics that drug companies use to stay ahead in the market

Color Genomics announce investment round of $45M led by General Catalyst with participation from the U2 front man

Straight out of San Diego, California, comes next-generation mapping for structural variations in the genome

As founder of three different data-driven companies, Atul Butte knows a thing or two about biotech entrepreneurship

Festival of Genomics California is here once again, and we’ve got the inside scoop on what makes San Diego such a special place for genomics

Oh, it’s that time again… from precision oncology to the Million Veteran Program, enjoy our pick of week’s best science bits!

UC Berkeley look to subpoena George Church as part of on-going CRISPR patent dispute

Merja Mehto from Thermo Fisher Scientific takes us through the intricacies of sample preparation, the crucial first step in molecular science

How can young scientists make the leap from academia to business? BioMed Central’s Dana Berry takes a look at life as a biotech entrepreneur

Scientists have begun to move into the £650 million Francis Crick Institiute in London and take up residence in their new labs

What underlies disruptive scientific advancement? Marc Hogenbirk of Bluebee makes the case that many advances are driven by the availability of data

Rumours: whether you’re spreading them, or just listening to the legendary Fleetwood Mac album, we have the roundup for you

A new world of genomic research, featuring Atul Butte, Roger Lasken, Stephen Kingsmore, and the genomics capital of the world

Consortium gathers in San Diego to create new paths to identifying currently undiagnosed illnesses

Patent litigation is a costly process, but according to STAT News, the sums involved in the CRISPR dispute are soaring